Correlation Between Elbit Systems and Rekah Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elbit Systems and Rekah Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elbit Systems and Rekah Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elbit Systems and Rekah Pharmaceutical Industry, you can compare the effects of market volatilities on Elbit Systems and Rekah Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elbit Systems with a short position of Rekah Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elbit Systems and Rekah Pharmaceutical.

Diversification Opportunities for Elbit Systems and Rekah Pharmaceutical

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Elbit and Rekah is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Elbit Systems and Rekah Pharmaceutical Industry in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rekah Pharmaceutical and Elbit Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elbit Systems are associated (or correlated) with Rekah Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rekah Pharmaceutical has no effect on the direction of Elbit Systems i.e., Elbit Systems and Rekah Pharmaceutical go up and down completely randomly.

Pair Corralation between Elbit Systems and Rekah Pharmaceutical

Assuming the 90 days trading horizon Elbit Systems is expected to generate 0.61 times more return on investment than Rekah Pharmaceutical. However, Elbit Systems is 1.63 times less risky than Rekah Pharmaceutical. It trades about 0.24 of its potential returns per unit of risk. Rekah Pharmaceutical Industry is currently generating about 0.11 per unit of risk. If you would invest  8,556,000  in Elbit Systems on August 29, 2024 and sell it today you would earn a total of  714,000  from holding Elbit Systems or generate 8.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elbit Systems  vs.  Rekah Pharmaceutical Industry

 Performance 
       Timeline  
Elbit Systems 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Elbit Systems are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Elbit Systems sustained solid returns over the last few months and may actually be approaching a breakup point.
Rekah Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rekah Pharmaceutical Industry has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Rekah Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Elbit Systems and Rekah Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elbit Systems and Rekah Pharmaceutical

The main advantage of trading using opposite Elbit Systems and Rekah Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elbit Systems position performs unexpectedly, Rekah Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rekah Pharmaceutical will offset losses from the drop in Rekah Pharmaceutical's long position.
The idea behind Elbit Systems and Rekah Pharmaceutical Industry pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes